Pnc Financial Services »

Cerevel Therapeutics Hldng I shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $276k 6.5k 42.40
2023-09-30 $208k 9.5k 21.83
2023-06-30 $179k 5.6k 31.79

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Erie Indty Cl A (ERIE)
V.F. Corporation (VFC)
Ishares Tr Msci Usa Qlt F (QUAL)
Wisdomtree Tr Us Qtly Div Gr (DGRW)
Procter & Gamble Company (PG)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Home Depot (HD)
Ishares Tr Msci Intl Qual (IQLT)

View all positions for Pnc Financial Services

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I